Rare diseases
Investigational molecules
Locations
Barfusserplatz 3, 4051
Clinical research in Tuberous Sclerosis Complex focuses on neurological and developmental manifestations in children, adolescents, and young adults, with attention to seizure-related disease burden and associated functional impact.
The therapeutic interest in this area centers on symptom control within the broader management of a complex epilepsy-associated disorder.
Noema Pharma AG runs clinical trials in conditions such as Trigeminal neuralgia, Tuberous sclerosis complex, Tourette's disorder, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
Denmark
Italy
BelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
